Bifidobacterium Infantis
Complete medical breakdown of Bifidobacterium Infantis. Understand the pharmacokinetics, clinical indications, and how to safely integrate it into your protocol.
Clinical Summary
Strain specific for Irritable Bowel Syndrome (IBS). Normalizes the ratio of pro-inflammatory to anti-inflammatory cytokines.
Pharmacokinetics & Bioavailability
When evaluating Bifidobacterium Infantis, the most critical factor is its absorption rate. Currently, the clinical bioavailability score for this specific chemical form is rated at N/A.
This high absorption rate ensures that the active compound reaches systemic circulation without causing excessive gastrointestinal distress, provided it is taken correctly.
Optimal Protocol Instructions
- Best Time: With a meal
- Elemental Dose: 1 Billion CFU
Contraindications & Warnings
Do not take Bifidobacterium Infantis without consulting your physician if you fall into any of the following categories.
Severe immunodeficiency
Medical Board Pick
We have analyzed the raw material sourcing for Bifidobacterium Infantis to ensure it meets strict clinical standards.
Supports our independent research